Approved PLCO Projects
Here you can browse the complete list of projects for PLCO whose requests for data/biospecimens were approved.
Name | Principal Investigator | Institution | Study | Date Approved | Project ID |
---|---|---|---|---|---|
Advanced Tool for Medical Image Analysis and Processing for Colorectal Cancer (CRC) Detection Using Artificial Intelligence | Sebastian Kraszewski | Faculty of Fundamental Problems of Technology, Wroclaw University of Science and Technology | PLCO | Dec 16, 2024 | PLCOI-1764 |
Data-Driven Breast Cancer Research: Machine Learning Applications and Deep Learning Approaches for Early Detection and Prognosis of Breast Cancer | Manisha Sharma | KIET GROUP OF INSTITUTIONS GHAZIABAD | PLCO | Dec 16, 2024 | PLCOI-1758 |
Estimating healthy volunteer effects in the PLCO | Filip Pirsl | National Cancer Institute | PLCO | Dec 16, 2024 | PLCO-1767 |
Comparison and Evaluation of Different Methods for Uncertainty Quantification in Machine Learning | Katharina Juliane Lempe | Universität Leipzig, Medizinische Fakultät, Innovation Center Computer Assisted Surgery | PLCO | Dec 16, 2024 | PLCO-1763 |
PrePCa: Prostate Cancer Prediction Based on Multimodal Data | Maria Dech Pons | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. | PLCO | Dec 9, 2024 | PLCO-1760 |
Nonparametric Percentile Curve Estimation for Prostate-Specific Antigen | Oke Gerke | Odense University Hospital | PLCO | Dec 4, 2024 | PLCO-1754 |
An artificial intelligence tool for therapeutic optimization in early invasive breast cancer patients. | Grégoire Gessain | Spotlight Medical | PLCO | Dec 4, 2024 | PLCOI-1753 |
Artificial Intelligence-Driven Models for Predicting Prognosis in Non-Small Cell Lung Cancer in Egypt with a Global Comparison | Nourhan Mohamed | Medical Research Institute | PLCO | Nov 21, 2024 | PLCOI-1748 |
Use of Breast Cancer Risk Reducing Medications | Paul Pinsky | National Institutes of Health | PLCO | Nov 19, 2024 | PLCO-1749 |
Detection of lung disease using deep learning | Himanshu Joshi | Drongo AI pvt LTD | PLCO | Nov 15, 2024 | PLCOI-1747 |
Exploring Multimodal Factors Influencing Breast Cancer Risk: A Data-Driven Approach | Oliver Díaz | Universitat de Barcelona | PLCO | Nov 12, 2024 | PLCO-1742 |
A Hybridized machine learning based survival prediction of ovarian cyst | Ovoh Oghenefego | Delta State University Abraka | PLCO | Nov 12, 2024 | PLCO-1740 |
Identifying Survival Phenotypes in High-Grade Serous Ovarian Cancer by Application of AI to Digital Pathology | Ernst Lengyel | University of Chicago | PLCO | Nov 12, 2024 | PLCOI-1737 |
Prostate Cancer Screening using Machine Learning | Jerry John Rawlings Mensah | Virginia Commonwealth University | PLCO | Nov 5, 2024 | PLCO-1732 |
Science Fair | Caspar McNulty | Swanson Middle School | PLCO | Nov 5, 2024 | PLCO-1725 |
Development of Models for Predicting Clinical Outcomes from H&E Stained Whole Slide Images | Zoltan Szallasi | Boston Children's Hospital | PLCO | Nov 5, 2024 | PLCOI-1720 |
The growing incidence of of colorectal cancer among those under 55 years age in The United States | Harrinique Deveaux | Florida State University | PLCO | Nov 5, 2024 | PLCO-1727 |
Surrogate endpoints for cancer screening trials | Adam Brentnall | Queen Mary University of London | PLCO | Nov 5, 2024 | PLCO-1719 |
Automatic Gleason Grading to Predict Survival | Anne Martel | Sunnybrook Research Institute | PLCO | Oct 21, 2024 | PLCOI-1716 |
An explainable liver disease screening-based machine learning model | Angélica Atehortúa | ISGlobal Barcelona Institute for Global Health | PLCO | Oct 17, 2024 | PLCO-1712 |